Onderneming NanoVibronix Inc OTC Bulletin Board
Aandelen
NAOV
US63008J1088
Medische apparatuur, benodigdheden & distributie
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Noninvasive Biological Response-activating Devices
100,0
%
| 1 | 100,0 % | 2 | 100,0 % | +203,59% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
94,7
%
| 1 | 94,4 % | 2 | 94,7 % | +204,51% |
Europe
4,4
%
| 0 | 3,3 % | 0 | 4,4 % | +304,00% |
Australia
0,8
%
| 0 | 1,2 % | 0 | 0,8 % | +111,11% |
Israel
0,0
%
| - | - | 0 | 0,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Harold Jacob
FOU | Founder | 69 | 01-09-03 |
Brian Murphy
CEO | Chief Executive Officer | 67 | 13-10-16 |
Stephen Brown
DFI | Director of Finance/CFO | 67 | 03-02-15 |
Lindsey Harrison
SAM | Sales & Marketing | - | 01-04-21 |
Itai Levinson
SAM | Sales & Marketing | - | 01-04-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Thomas Mika
BRD | Director/Board Member | 72 | 27-04-15 |
Chairman | 74 | 14-11-16 | |
Aurora Cassirer
BRD | Director/Board Member | 72 | 01-01-22 |
Harold Jacob
FOU | Founder | 69 | 01-09-03 |
Michael Ferguson
BRD | Director/Board Member | 53 | 27-04-15 |
Martin Goldstein
BRD | Director/Board Member | 56 | 25-03-15 |
Brian Murphy
CEO | Chief Executive Officer | 67 | 13-10-16 |
Maria Schroeder
BRD | Director/Board Member | 65 | 13-01-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 2 784 354 | 2 772 619 ( 99,58 %) | 0 | 99,58 % |
Bedrijfsgegevens
NanoVibronix, Inc.
525 Executive Boulevard
10523-1240, Elmsford
+(914) 233-3004
http://www.nanovibronix.comSector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-7,16% | 178 mld. | |
-1,23% | 107 mld. | |
-4,86% | 67,04 mld. | |
-4,28% | 47,23 mld. | |
+10,32% | 44,62 mld. | |
+8,14% | 42,5 mld. | |
+15,76% | 29,99 mld. | |
+15,53% | 25,22 mld. | |
-5,88% | 24,14 mld. |